Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
8 Patents
#541 in San Francisco, CA
#8,543 in California
#35,941 in US
Olema Pharmaceuticals, Inc.
Forward Citations = 36
14 inventors:
San Francisco, CA, United States of America
Olema Pharmaceuticals, Inc.
% Expired Patents = 25.0
EPO Patents = 2
Trademarks = 3
Forward Citations = 36
Loading Chart...
Loading Chart...
14 inventors (with patents filed for the assignee):
David C Myles (8 out of 26 patents)
Peter J Kushner (7 out of 17 patents)
Cyrus L Harmon (7 out of 7 patents)
4. Brian R Hearn (1 out of 11 patents)
5. Susanta Samajdar (1 out of 27 patents)
6. Chandregowda Venkateshappa (1 out of 6 patents)
7. Leslie Carol Hodges Gallagher (1 out of 1 patent)
8. Kalisankar Bera (1 out of 1 patent)
9. David Yeghikyan (1 out of 1 patent)
10. Reena Chawla (1 out of 1 patent)
11. Richard Sun (1 out of 1 patent)
12. Leslie Hodges Gallagher (1 out of 1 patent)
13. Suraj Tatyasaheb Gore (1 out of 2 patents)
14. Raymond A Ng (1 out of 1 patent)
8 patents:
Company Overview
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapies. The company is dedicated to advancing precision medicine by targeting therapeutically relevant molecular pathways. Olema's pipeline includes innovative treatments for hormone receptor-positive breast cancer and other solid tumors.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Olema Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/olema-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]